• Login
    View Item 
    •   UZ eScholar Home
    • Faculty of Medicine and Health Sciences
    • Faculty of Medicine and Health Sciences ETDs
    • Faculty of Medicine & Health Sciences e-Theses Collection
    • View Item
    •   UZ eScholar Home
    • Faculty of Medicine and Health Sciences
    • Faculty of Medicine and Health Sciences ETDs
    • Faculty of Medicine & Health Sciences e-Theses Collection
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Co-morbidity of diabetes mellitus and HIV in patients attending the ART clinic Parirenyatwa hospital 2015

    Thumbnail
    View/Open
    Tsikira_Co-morbidity_of_diabetes_mellitus_and_HIV_in_patients_attending_the_ART_clinic_Parirenyatwa_hospital_.pdf (2.177Mb)
    Date
    2016-11
    Author
    Tsikira, Tafadzwa
    Metadata
    Show full item record

    Abstract
    Background: Zimbabwe has a double burden of diseases, with HIV epidemic and increased prevalence of diabetes mellitus. Since the roll out of Anti Retroviral Therapy in 2004 at Parirenyatwa OI clinic, Nucleoside Reverse Transcriptase Inhibitors have been the backbone of antiretroviral therapy. At least 10% of OI clients at the institution are on 2nd line regimen with Protease Inhibitors. These drugs cause metabolic derangements which are potentially Diabetogenic. With improved care in HIV management, patients are living long enough to experience environmental and behavioural risk factors for diabetes mellitus. However diabetic screening is not done at Parirenyatwa OI clinic and the disease burden of HIV/Diabetes co-morbidity is not known. Methods: An analytic cross-sectional study was conducted. Questionnaires were used to collect data on patient’s socio-demographic characteristics, medical history and symptoms of diabetes mellitus. Random blood sugar and glycated haemoglobin tests were done to ascertain diabetes status. Results: Prevalence of diabetes was 15.42%. Treatment with Protease inhibitors (POR 2.36; 95% CI 1.06-5.23) and a CD4 count at diagnosis of HIV greater than 500 (POR 3.74; 95% CI 1.26-11.09) were associated with development of diabetes mellitus with statistical significance. Smoking (POR 2.34; 95% CI 0.69-7.96), alcohol abuse (POR 1.81; 95% CI 0.74-4.40) being overweight (POR 1.79; 95% CI 0.85-3.79), were also associated with the development of diabetes but not statistically significant. Conclusions: Behavioural risk factors like smoking, alcohol use and being overweight were associated with developing diabetes. Protease inhibitors use was also associated with the development of diabetes mellitus.
    URI
    http://hdl.handle.net/10646/2944
    Subject
    Diabetes Mellitus
    Antiretroviral Therapy
    HIV
    Collections
    • Faculty of Medicine & Health Sciences e-Theses Collection [158]

    University of Zimbabwe: Educating To Change Lives!
    DSpace software copyright © 2002-2020  DuraSpace | Contact Us | Send Feedback
     

     

    Browse

    All of UZ eScholarCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage StatisticsView Google Analytics Statistics

    University of Zimbabwe: Educating To Change Lives!
    DSpace software copyright © 2002-2020  DuraSpace | Contact Us | Send Feedback